244 results on '"Perlmutter, J S"'
Search Results
2. New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death Dying from HDQLIFE (a patient-reported outcomes measurement system)
3. HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties
4. Transient dystonia correlates with parkinsonism after 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in non- human primates
5. A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning
6. New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system)
7. Targeted sequencing of TOR1A in primary dystonia: 1449
8. Convergent validity of the revised motor and psychiatric TWSTRS modules of the comprehensive cervical dystonia rating scale (CCDRS): 1346
9. Carboxyfullerene rescue of MPTP-induced nigrostriatal injury in nonhuman primates: 697
10. Reliability and validity of the revised TWSTRS psychiatric module (TWSTRS-PSYCH) of the comprehensive cervical dystonia rating scale (CCDRS): 484
11. The dystonia coalition: Two years of progress
12. Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinsonʼs disease
13. Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys
14. Effects of deep brain stimulation of dorsal versus ventral subthalamic nucleus regions on gait and balance in Parkinsonʼs disease
15. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease
16. Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease
17. Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease
18. Neuroimaging biomarkers of Parkinson disease progression?: O97
19. Absence of Previously Reported Variants in the Scna (G88c and G209a), Nr4a2 (T291d and T245g) and the Dj-1 (T497c) Genes in Familial Parkinsonʼs Disease From the GenePd Study
20. Pathophysiology of parkinsonism due to hydrocephalus
21. Long term treatment and disease severity change brain responses to levodopa in Parkinson’s disease
22. PET Measured Evoked Cerebral Blood Flow Responses in an Awake Monkey
23. HDQLIFE Meaning and Purpose Scale
24. HDQLIFE
25. HDQLIFE Concern With Death and Dying Scale
26. A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning.
27. Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6
28. CSF proteins and resting-state functional connectivity in Parkinson disease
29. Smoking and Parkinson disease: Where there is smoke there may not be fire
30. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease
31. Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases
32. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures
33. To scan or not to scan: DaT is the question
34. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure
35. Neurologist care in Parkinson disease: A utilization, outcomes, and survival study
36. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure
37. The Authors Reply
38. Novel THAP1 sequence variants in primary dystonia
39. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
40. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study
41. THE IMPACT OF LITIGATION ON NEUROLOGIC RESEARCH
42. The impact of litigation on neurologic research
43. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: The GenePD Study
44. RECOMMENDATIONS FOR BRADYKINESIA ASSESSMENT IN PARKINSON DISEASE
45. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study
46. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders
47. Stimulation of STN impairs aspects of cognitive control in PD
48. A haplotype at the PARK3 locus influences onset age for Parkinson’s disease
49. Blind men and blinking elephants
50. Ptosis as a remote effect of therapeutic botulinum toxin B injection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.